Fresenius Medical Care AG & Co. KGaA ADR logo

Fresenius Medical Care AG & Co. KGaA ADR (FMS)

Market Closed
17 Jul, 20:00
NYSE NYSE
$
24. 11
+0.02
+0.083%
$
12.92B Market Cap
20.41 P/E Ratio
4.87% Div Yield
552,400 Volume
0 Eps
$ 24.09
Previous Close
Add Transaction
Day Range
24.05 24.36
Year Range
20.02 27.64
Want to track FMS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

FMS closed today higher at $24.11, an increase of 0.083% from yesterday's close, completing a monthly increase of 12.9803% or $2.77. Over the past 12 months, FMS stock gained 1.9019%.
FMS pays dividends to its shareholders, with the most recent payment made on Jun 08, 2026. The next estimated payment will be in In 10 months on Jun 08, 2027 for a total of $0.86435.
The last earnings report, released on May 04, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.0377%, based on the last three reports.
Fresenius Medical Care AG & Co. KGaA ADR has completed 1 stock splits, with the recent split occurring on Dec 04, 2012.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on NYSE (USD).

FMS Chart

People also search for

ABT
Abbott Laboratories
$ 100.68
+1.8719%
PFE
Pfizer Inc.
$ 25.05
-0.358%
CVS
CVS Health Corporation
$ 107.47
+0.9108%
SYK
Stryker Corporation
$ 319.87
-3.4209%
MDT
Medtronic plc
$ 83.2
-0.4308%
Fresenius Medical: High Yield, Utilities-Like Stock At Valuation Lows

Fresenius Medical: High Yield, Utilities-Like Stock At Valuation Lows

FMS is a defensive dialysis services provider with stable and recurring demand and regulated pricing. Profitability is recovering as FME25+ cost savings flow through the business. The stock offers attractive shareholder returns through high free cash flow, dividends, and large buybacks.

Seekingalpha | 1 week ago
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now

Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now

FMS??? margin gains, HighVolumeHDF rollout and AI-driven care are boosting momentum, but reimbursement and volume risks remain.

Zacks | 1 week ago
FMS and Home Dialysis: How 5008X Could Reset Demand

FMS and Home Dialysis: How 5008X Could Reset Demand

FMS scales 5008X high-volume HDF and expands home dialysis, aiming for benefits later in 2026 and a bigger payoff in 2027+.

Zacks | 1 month ago

Fresenius Medical Care AG & Co. KGaA ADR Investors

Name Quantity Cost Value Profit ($) Gain (%)
DI
David Izzi Brown, LISLE/CUMMINGS Inc.
419 $9,486 $10,083.23 $597.23 6.3%
CE
Curtis Ellergodt Rothschild Investment LLC
604 $13,512.15 $14,535.26 $1,023.11 7.57%
Dodge & Cox
Dodge & Cox Dodge & Cox Funds
4.17M $92.99M $100.44M $7.45M 8.01%
Charles Brandes
Charles Brandes Brandes Investment Partners
1.61M $36.34M $38.77M $2.43M 6.69%
Richard S. Pzena
Richard S. Pzena Pzena Investment Management
15.05M $292.9M $362.32M $69.42M 23.7%

Fresenius Medical Care AG & Co. KGaA ADR (FMS) FAQ

What is the stock price today?

The current price is $24.11.

On which exchange is it traded?

Fresenius Medical Care AG & Co. KGaA ADR is listed on NYSE.

What is its stock symbol?

The ticker symbol is FMS.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 4.87%.

What is its market cap?

As of today, the market cap is 12.92B.

Has Fresenius Medical Care AG & Co. KGaA ADR ever had a stock split?

Fresenius Medical Care AG & Co. KGaA ADR had 1 splits and the recent split was on Dec 04, 2012.

Fresenius Medical Care AG & Co. KGaA ADR Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Helen Giza CEO
NYSE Exchange
358029106 CUSIP
DE Country
108,165 Employees
22 May 2026 Last Dividend
4 Dec 2012 Last Split
- IPO Date

Overview

Fresenius Medical Care AG is a leading global provider in the field of dialysis and related services, catered towards individuals suffering from renal diseases. Established in 1996 and headquartered in Bad Homburg, Germany, the company has a broad reach extending across Germany, North America, and other international locations. Fresenius Medical Care AG specializes in delivering dialysis treatment and associated laboratory and diagnostic services mainly through its extensive network of outpatient dialysis clinics. Additionally, the company holds contracts with hospitals in the United States to offer dialysis services to hospitalized end-stage renal disease (ESRD) patients and those facing acute kidney failure. Beyond its core services, Fresenius Medical Care AG is engaged in the development, manufacture, and distribution of a wide range of health care products, as well as in the development and licensing of renal pharmaceuticals. It serves a diverse clientele, including dialysis clinics, hospitals, and specialized treatment facilities, through direct sales and a blend of local sales forces, independent distributors, dealers, and sales agents.

Products and Services

Fresenius Medical Care AG provides a comprehensive suite of products and services tailored to meet the needs of renal disease patients and health care providers:

  • Dialysis Services and Support: The company delivers dialysis treatment alongside laboratory and diagnostic services through its outpatient clinics. It also provides training, clinical monitoring, follow-up assistance, and home delivery of supplies for patients, alongside contracted dialysis services for hospitalized patients.
  • Health Care Products: The product line includes items such as polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, solutions, and granulates. These are essential for performing dialysis treatment both in clinics and at home.
  • Renal Pharmaceuticals: Fresenius Medical Care AG works on the development, acquisition, and in-licensing of renal pharmaceuticals. The company also supplies renal medications directly to patients' homes or dialysis clinics, ensuring that those undergoing treatment have easy access to their necessary medications.
  • Water Treatment Systems and Other Supplies: The comprehensive list of supplies includes bloodlines, hemodialysis concentrates, peritoneal dialysis solutions, and systems for water treatment, which ensure the safe conduct of dialysis treatment by managing the cleanliness and purity of water used.
  • Cardiopulmonary and Apheresis Products: Beyond renal care, the company also offers products for acute cardiopulmonary support and apheresis procedures, addressing the needs of patients with cardiovascular issues or those requiring blood purification.
  • Specialized Medical Services: Fresenius Medical Care AG provides additional specialized services, such as vascular, cardiovascular, and endovascular specialty services, ambulatory surgery center management for vascular care, and professional services for nephrology and cardiology. These are intended to complement the core dialysis services by addressing the broader health needs of renal disease patients.

Contact Information

Address: Else-KrOener Strasse 1
Phone: 49 6172 608 2522